Learning versus confirming in clinical drug development¶
Sheiner, L. B. (1997). Learning versus confirming in clinical drug development. Clinical Pharmacology & Therapeutics, 61(3), 275-291.
Cited by¶
2 citations across 2 artifacts.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Dose-Response Relationship
- This formal machinery is the foundation of the model-based, "learn-and-confirm" approach to rational drug design that Sheiner (1997) advocated as a substitute for purely empirical dose-finding in clinical pharmacology.
This sourceArgues for a model-based learn-and-confirm cycle using dose-response/PK-PD models to design dose-finding studies; supports D47-029 (the Hill equation as the formal scaffolding of rational drug design, not purely empirical curve-fitting).
- This formal machinery is the foundation of the model-based, "learn-and-confirm" approach to rational drug design that Sheiner (1997) advocated as a substitute for purely empirical dose-finding in clinical pharmacology.
- PK/PD Modeling (Pharmacokinetics / Pharmacodynamics)
- PK/PD is clarifying because it integrates disparate quantitative findings about a drug — absorption rate, distribution volume, elimination rate, target affinity, signal transduction, clinical endpoint — into a unified mathematical framework that predicts the clinical time course from dose, an integrative role Sheiner (1997) articulated in his "Learning versus Confirming" framing of clinical drug development.
This sourceArgues for a model-based "learn-and-confirm" cycle in drug development that uses dose-response and PK/PD models to design dose-finding studies; reframes the Hill equation as the formal scaffolding of rational drug design rather than purely empirical curve-fitting.
- PK/PD is clarifying because it integrates disparate quantitative findings about a drug — absorption rate, distribution volume, elimination rate, target affinity, signal transduction, clinical endpoint — into a unified mathematical framework that predicts the clinical time course from dose, an integrative role Sheiner (1997) articulated in his "Learning versus Confirming" framing of clinical drug development.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:fb13a3a49817 · see in the full table